Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple bacterial surface antigens on Pasteurella multocida, Escherichia coli, Trueperella pyogenes, and Fusobacterium necrophorum represent a composite target profile for veterinary biologicals. These antigens include outer membrane proteins, lipopolysaccharides, and adhesins that are essential for the virulence and survival of these pathogens in livestock [1, 4]. Pasteurella multocida and Escherichia coli are major causes of respiratory and enteric diseases, while Trueperella pyogenes (formerly Arcanobacterium pyogenes) and Fusobacterium necrophorum are primarily associated with pyogenic infections and liver abscesses [2, 3]. Therapeutic strategies targeting these antigens, such as polyvalent antisera (e.g., Poly-Serum), provide passive immunity by delivering antibodies that facilitate bacterial opsonization and neutralization [5]. This approach is particularly relevant in treating complex, polymicrobial conditions like Bovine Respiratory Disease and liver abscess complexes where multiple pathogens contribute to the pathology. Effective targeting of these surface molecules helps reduce bacterial load and mitigates the severity of clinical disease in affected animals [1, 5].
Passive or active immunization targeting surface antigens to promote opsonization, neutralization of toxins, and complement-mediated lysis of the specified bacterial pathogens [5].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple bacterial surface antigens (Pasteurella multocida, Escherichia coli, Trueperella pyogenes, and Fusobacterium necrophorum).